Search Details

Word: pharma (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...OxyContin's time-release formulation, patients with pain who take the drug do not experience the heroin-like euphoria you mentioned. Wrong perceptions about addiction--and mislabeling legitimate patients as abusers--can result in the unnecessary withholding of opioid medications from patients in need. You stated that Purdue Pharma is facing pressure from prosecutors to minimize forged prescriptions. In fact, the company took the initiative six months ago to meet with officials to assist efforts to stop illegal drug trafficking. You also suggested that several deaths in Maine were attributed to overdoses of OxyContin. However, I have confirmed that...

Author: /time Magazine | Title: Letters: Jan. 29, 2001 | 1/29/2001 | See Source »

...everyone agrees that OxyContin is problematic. Dr. David Haddox, senior medical director for Purdue Pharma, the drug's manufacturer, insists doctors are not overprescribing. But the company has a lot to lose if the controversy lingers and doctors take their patients off it. Last April the Wall Street Journal reported that OxyContin sales increased 95% in one year, generating $600 million in sales for Purdue Pharma. Indeed, the drug, introduced in 1995, has been hailed as a miracle; it eases chronic pain because its dissolvable coating allows a measured dose of the opiate oxycodone to be released into the bloodstream...

Author: /time Magazine | Title: The Potent Perils Of a Miracle Drug | 1/8/2001 | See Source »

Biotech companies are notorious for moving ahead with tests too quickly. But, Weisbrod notes, "that still doesn't account for this huge discrepancy." His top picks, too, expect to have drugs approved within two years: Biochem Pharma (hepatitis) and Centocor (blood clots). Another fan of companies with late-stage drugs is Evan Sturza, editor of Sturza's Medical Investment Letter, whose top picks are Aviron (flu), Gilead Sciences (HIV, hepatitis) and Sepracor (side effects from Prozac, Claritin and others...

Author: /time Magazine | Title: Why Biotech Stocks Are Cheap | 5/18/1998 | See Source »

Unknown startups like Amgen, Genentech, Genzyme and Biogen scrambled to harness the natural machinery for weaving proteins within each living cell. With the support of "big pharma," the giant pharmaceutical companies of the past, these startups rolled out scores of blockbuster drugs that addressed diseases like hepatitis and cancer in entirely novel ways...

Author: By Nicholas A. Nash, CRIMSON STAFF WRITER | Title: Start-Ups at Cutting Edge of Science Innovations | 4/14/1998 | See Source »

Such Knowledge is critical for pharmaceutical companies, which must constantly seek out new drugs to interact with new targets to find new cures, and Millennium already has lucrative alliances with six members of "big pharma," including Monsanto and Eli Lilly...

Author: By Nicholas A. Nash, CRIMSON STAFF WRITER | Title: Start-Ups at Cutting Edge of Science Innovations | 4/14/1998 | See Source »

First | Previous | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | Next | Last